His-Purkinje Conduction System Pacing in Atrioventricular Block New Insights Into Site of Conduction Block

OBJECTIVES This study aims to assess the safety and feasibility of achieving His-Purkinje conduction system pacing (HPCSP) in consecutive patients with atrioventricular block (AVB) and to describe the site of conduction block in patients with infranodal AVB. BACKGROUND HPCSP has evolved as the preferred form of physiologic pacing. Left bundle branch area pacing (LBBAP) has emerged as an effective alternative to His bundle pacing (HBP). METHODS Consecutive patients with AVB referred for pacemaker implantation were included in the study. HBP or LBBAP was attempted in all patients. Site of conduction block was identified as nodal or infranodal (intra-Hisian or infraHisian) AVB. RESULTS HPCSP was attempted in 333 consecutive patients with AVB and was successful in 322 (97%) patients. HBP was achieved in 140 patients, LBBAP in 179 patients, and both in 3 patients. Site of conduction block was nodal in 55% and infranodal in 45% (intra-Hisian 89%; infra-Hisian 4%; indeterminate 7%). QRS duration at baseline was 111 +/- 27 versus 129 +/- 31 (P < 0.001) compared to 126 +/- 24 vs 125 +/- 21 milliseconds (P = 0.75) during HBP and LBBAP, respectively. HBP thresholds at implant were higher compared to LBBAP (1.2 +/- 0.7 Vat 0.9 milliseconds vs 0.6 +/- 0.3 V at 0.5 milliseconds; P < 0.001) but remained stable during follow-up. Lead revision was required in 3% and 2% of patients with HBP and LBBAP, respectively. CONCLUSIONS HPCSP pacing was successfully performed in 97% of unselected patients with AVB irrespective of the site of conduction block. True infra-Hisian block (distal His-Purkinje conduction disease) is rare. HBP and LBBAP were complementary in achieving stable and low capture thresholds. (C) 2022 by the American College of Cardiology Foundation.

Automated summary

This study aimed to assess the safety and feasibility of His-Purkinje conduction system pacing (HPCSP) in patients with atrioventricular block (AVB) and to describe the site of conduction block. HPCSP was successful in 97% of patients with AVB, and HBP and LBBAP were complementary in achieving stable and low capture thresholds.